The kinetics of ligand gated ion channels are tuned to permit diverse roles in cellular signaling. To follow high-frequency excitatory synaptic input, postsynaptic AMPA-type glutamate receptors must recover rapidly from desensitization. Chimeras between AMPA and the related kainate receptors demonstrate that the ligand binding domains alone control the lifetime of the desensitized state. Mutation of nonconserved amino acids in the lower lobe (domain 2) of the ligand binding domain conferred slow recovery from desensitization on AMPA receptors, and fast recovery on kainate receptors. Singlechannel recordings and a correlation between the rate of deactivation and the rate of recovery across panels of mutant receptors revealed that domain 2 also controls ion channel gating. Our results demonstrate that the same mechanism that ensures fast recovery also sharpens the response of AMPA channels to synaptically released glutamate.
INTRODUCTION
Glutamate receptors mediate fast excitatory transmission in the brain and are candidate substrates for storage of memories through plastic changes in their synaptic distributions. The AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid) subtype of glutamate receptors can follow synaptic activity in the kilohertz range (Taschenberger and von Gersdorff, 2000) because they allow glutamate to unbind rapidly and can recover from desensitization quickly (Colquhoun et al., 1992) . In contrast, both recombinant and native kainate receptors recover from desensitization about 100-fold more slowly (Bowie and Lange, 2002; Paternain et al., 1998) . Desensitization occurs at synapses even during a single postsynaptic response (Otis et al., 1996) , although this may be masked by fast recovery and lateral mobility of receptors (Frischknecht et al., 2009 ). Short-term depression due to desensitization facilitates neuronal computation (Rothman et al., 2009 ) and normal desensitization of AMPA receptors also appears critical for brain development (Christie et al., 2010) .
AMPA and kainate receptors have the same overall structure (Sobolevsky et al., 2009; Das et al., 2010) . A global axis of 2-fold symmetry, perpendicular to the membrane plane, defines dimers of ligand binding domains (LBDs). AMPA and kainate receptors desensitize when this dimer relaxes (Chaudhry et al., 2009a; Sun et al., 2002; Armstrong et al., 2006) , but molecular determinants of the lifetime of the resulting desensitized state are unknown. Each ligand binding domain is a clamshell which closes upon glutamate binding. Some hydrogen bonds that form between the jaws of the binding domain in GluK2 following glutamate binding are absent in AMPA receptors (Weston et al., 2006b ). However, mutant kainate receptors that lack these interactions still recover slowly from desensitization. Introducing similar interactions to AMPA receptors slows deactivation and decreases glutamate potency sharply, but does not slow recovery profoundly. Hence, interactions distinct from those at the jaws of the ligand binding domain must control the rate of recovery from the desensitized state.
Studies of chimeric glutamate receptors have elucidated glutamate receptor gating (Gielen et al., 2009; Rosenmund et al., 1998) , desensitization , and assembly (Ayalon et al., 2005) . In a landmark study, chimeras between GluA3 and GluK2 defined the ligand binding domain (Stern-Bach et al., 1994) , but kinetic comparisons were impossible because some chimeras were nonfunctional. We constructed fully functional reciprocal chimeras of AMPA and kainate receptors, examined their biophysical properties for the first time and employed kinetic modeling to understand their behavior. Subsequently, we identified residues that determine the lifetime of the desensitized state in AMPA and kainate receptors. Our mutant screens reveal a surprising coregulation of channel gating behavior by distributed sites within the lower jaw of the LBD.
RESULTS

Chimeras of AMPA and Kainate Receptors with Exchanged Recovery Rates
The pore domains of AMPA and kainate receptors are similar, and removing the amino terminal domain (ATD) does not alter recovery (Pasternack et al., 2002; Plested and Mayer, 2007) . For these reasons, and because the LBDs rotate upon entry to desensitization (Armstrong et al., 2006) , we hypothesized that interactions determining the rate of recovery from desensitization were localized in the ligand binding domains. We began our search for elements that control recovery from desensitization by constructing chimeric receptors in which we swapped the ligand binding cores between GluA2 (AMPA) and GluK2 (Kainate) receptors ( Figure 1A ). These subtypes are present in many native receptor complexes (Sans et al., 2003; Breustedt and Schmitz, 2004) and form recombinant homomeric receptors that differ about 100-fold in recovery rate. We called the chimeras B2P6, for the LBD from GluA2 with the pore and ATD of GluK2 (GluR6) and B6P2, for the LBD from GluK2 (GluR6) with the pore and ATD of GluA2.
Startlingly, in the B2P6 chimera, the presence of the GluA2 LBD conferred extremely fast recovery from desensitization, with a recovery rate of 63 ± 6 s À1 ( Figures 1B and 1C , Hodgkin-Huxley-type-fit slope = 2, n = 7), even faster than that of wild-type GluA2 (47 ± 6 s
À1
, n = 10). This rate of recovery is more than 100-fold quicker than that of GluK2 (0.47 ± 0.03 s À1 , monoexponential fit, n = 14). The inverse chimera, B6P2, including the GluK2 LBD, recovered slowly from desensitization (k rec = 0.39 ± 0.01 s À1 , monoexponential fit, n = 10 patches), also 100-fold slower than wild-type GluA2. To compare fairly between recovery relations with different slopes, we also calculated the time of 50% recovery (t 50 ) for chimeric and wildtype receptors ( Figure 1E ), which also indicated a complete exchange of the lifetime of the desensitized state with the ligand binding domain. These results show that no part of the kainate receptor outside the binding site contributes to the very slow recovery from desensitization observed in heterologously expressed wild-type GluK2 channels, and in native kainate receptors (Bowie and Lange, 2002; DeVries and Schwartz, 1999; Paternain et al., 1998) . Likewise, the fast recovery of recombinant and native AMPA receptors (Zhang et al., 2006; Colquhoun et al., 1992 ) must be explained entirely by determinants within the LBD.
Transplanted LBDs Behave as in Wild-Type Donors
The isolated LBDs of AMPA and kainate receptors are autonomous modules that recapitulate the properties of LBDs in full-length receptors (Armstrong and Gouaux, 2000; Mayer, 2005) . When activated by 10 mM glutamate, both the B2P6 and B6P2 chimeras exhibited fast activation and desensitization similar to wild-type receptors (Figure S1A available online), although the B2P6 chimera desensitized more slowly and less ). In contrast, wild-type GluK2 receptors recover 2 orders of magnitude more slowly (right panel, blue curve, monoexponential fit, k rec = 0.8 s À1 ).
(C) The B2P6 chimera recovers as rapidly from desensitization as wild-type GluA2 (red curve, Hodgkin-Huxley fit with slope 2, k rec = 27 s À1 ), whereas the inverse chimera, B6P2, has indistinguishable recovery from wild-type GluK2 (blue fitted curve, monoexponential fit k rec = 0.5 s À1 ).
(D) Hodgkin-Huxley type functions fitted to pooled data. For B2P6, k rec = 63 ± 6 s À1 for B2P6 (slope = 2, n = 7) and k rec = 0.39 ± 0.01 s À1 for B6P2 (slope = 1, n = 10). Dotted and dashed lines show recovery curves for wild-type GluA2 (slope = 2, n = 10) and wild-type GluK2 (slope = 1, n = 14), respectively. Error bars represent standard deviation of the mean (SDM).
(E) Bar plot summarizing exchange of half-recovery times (t 50 ) on a log scale. See also Figures S1 and S2 for further characterization of chimeric receptors.
profoundly than wild-type GluA2 (Table 1) . However, transplanting the binding domains might produce receptors with strongly shifted affinities for glutamate, which would be expected to alter the lifetime of the desensitized state in wild-type and mutant GluRs (Zhang et al., 2006; Weston et al., 2006b) . To check this, we determined concentration response relations for peak currents following fast application of glutamate ( Figure S1B ). Wild-type GluA2 had glutamate EC 50 of 1,100 ± 140 mM (n = 6 patches). Glutamate was about 9-fold more potent at activating wild-type GluK2 receptors (EC 50 = 130 ± 30 mM; n = 4, p = 1.6% versus WT A2; Student's t test). For the B2P6 chimera, the glutamate EC 50 was 470 ± 80 mM (n = 6; p = 30% versus WT K2 and 15% versus WT A2) and for the B6P2 chimera, it was 800 ± 150 mM (n = 4; p = 20% versus WT A2 and 8.8% versus WT K2). Thus glutamate activated both chimeras with a similar potency to the wild-type donors, consistent with limited differences in affinity for nondesensitized states. AMPA is barely active at homomeric kainate receptors (Egebjerg et al., 1991) , because it is sterically excluded from the GluK2 binding site (Mayer, 2005) . Consistent with these observations, and previously published radioligand binding studies (Stern-Bach et al., 1994) , AMPA (1 mM) activated the B2P6 chimera (61% ± 7% of response to 10 mM glutamate in the same patch, n = 7 patches) and wild-type GluA2, but failed to evoke a response in the B6P2 chimera ( Figure S1C ). Kainate only partially closes the LBD of GluA2 upon binding (Armstrong and Gouaux, 2000) and is a very weak partial agonist of the GluA2 channel (Plested and Mayer, 2009 ), but activates kainate receptors efficaciously. Kainate (1 mM) activated a rapidly desensitizing response in the B6P2 chimera that was about one-third the amplitude of that generated by 10 mM glutamate (k des = 240 ± 70 s À1 , peak 28% ± 11%, n = 5 patches), similar to the response of GluK2 wild-type receptors. The response of the B2P6 chimera to 1 mM kainate was small (4% ± 1% of the glutamate peak current, n = 4 patches). Such closely matching preferences for glutamatergic ligands strongly argues that the LBDs were transferred intact. We used selective allosteric modulators to check the integrity of the active dimer interface in the chimeric receptors. Cyclothiazide (CTZ; 100 mM) increased the steady state current in the presence of 10 mM glutamate about 4-fold, to 82% ± 2% of the peak (n = 5 patches) for the B2P6 chimera ( Figure S1D ). Cyclothiazide blocks desensitization in wild-type GluA2 by 96% (Sun et al., 2002) , but a point mutation in the CTZ binding site abolishes modulation (Partin et al., 1995) , so this inhibition of desensitization is consistent with an intact dimer-interface binding site for CTZ. Monovalent ions control the kinetics of GluK2 but do not affect GluA2 (Plested et al., 2008) . Ion (12) K2 T715E 0.54 ± 0.06 (7) 1 1,300 ± 100 156 ± 10 (5) 0.9 ± 0.5% 500 ± 100 (5) K2 R769Y K2 -RLE-4.6 ± 0.4 (11) 1 150 ± 10 180 ± 20 (10) 2.6 ± 0.5% 1,500 ± 100 (15) K2 ARLE-8.6 ± 0.7 (6) 1 80 ± 10 190 ± 40 (6) 2.6 ± 0.6% 1,500 ± 200 (6)
All recovery data were fitted with Hodgkin-Huxley-type relations with the slope fixed to either 1 or 2, as indicated. The terms k rec , k des , k deact are rates of recovery from desensitization, desensitization, and deactivation, respectively; t 50 is the half-time of recovery; I ss /I peak is the steady state current expressed as a percentage of the peak. Values are shown as mean ± SD of the mean. The five individual GluK2 point mutants listed here were combined to give double, triple, and quadruple mutants as indicated (in sequential order; dashes represent wild-type residues).
sensitivity was also swapped according to the donor of the binding domain ( Figure S1E ). The B6P2 chimera was strongly inhibited upon substitution of cations (CsCl peak current 0.3% ± 0.2% of that in NaCl, n = 5 patches), and anions (NaNO 3 peak current 36% ± 15%, n = 4 patches), similar to GluK2 wild-type channels (CsCl, 7%; NO 3 , 75%; Plested and Mayer, 2007) . Small disruptions of the ion binding sites generally invert sensitivity, so the active dimer arrangement in B6P2 channels must be similar to that in GluK2. The B2P6 chimera was completely insensitive to ion exchanges (peak currents, relative to NaCl: 94% ± 1% for CsCl; 95% ± 5%, NaNO 3 , n = 3, not shown). Glutamate (10 mM) activated a large steady state current at the B2P6 chimera (21% ± 1% of peak, n = 15 patches), reminiscent of the Willardiine series of partial agonists (Jin et al., 2003) . To check that glutamate remains a full agonist at the B2P6 chimera, we estimated open probability using noise analysis ( Figures S2A-S2D ). Wild-type GluA2 receptors have a high peak open probability (77% ± 7%, n = 5 patches), and the peak open probability of the B2P6 chimera was not significantly different (65 ± 5%, n = 5 patches; p > 0.05, randomization test). Weighted single-channel conductance was also similar (WT A2: 18 ± 3 pS; B2P6: 16 ± 1 pS). Additionally, we checked if quisqualate, which activates a larger current than glutamate in GluA2 mutants where domain closure is hindered (Robert et al., 2005) , could activate bigger responses than glutamate at the B2P6 construct (Figures S2E and S2F) . Currents activated by quisqualate (2 mM) and glutamate (10 mM) were similar in amplitude (Quis. peak current: 92% ± 8% of that evoked by 10 mM glutamate, n = 5 patches), suggesting that domain closure in the B2P6 channel is normal. These results exclude spurious partial agonism as an explanation for fast recovery, and suggest that the large steady state current in the B2P6 chimera is due to recovery that is even faster than wild-type GluA2.
Kinetic Simulations of Chimeric Receptors
Our recordings of the B2P6 and B6P2 chimeras displayed striking features that we reasoned could constrain parameters in simulations of receptor kinetics and thereby provide insight to the molecular mechanisms determining recovery from desensitization. Our aim was to identify if individual kinetic transitions could explain the observed behavior and, by comparing with existing biophysical studies (Robert et al., 2005; Zhang et al., 2008) , pinpoint the region of the LBD most likely to control recovery. Using a simplified model of GluR activation (see Figure 2A and Supplemental Experimental Procedures) , we tried three scenarios to account for changes in recovery rate. First, we varied the lifetime of a deep desensitized state (AD2), from which agonist dissociation was very slow. Second, alterations in the bound lifetime of glutamate might change recovery, and we simulated this on two backgrounds, with initially slow and fast recovery, respectively. Finally, we tested the hypothesis that the equilibrium between resting (AR) and desensitized states (AD) differs between AMPA and kainate receptors.
The rate of recovery from desensitization was sensitive to rate changes in each case. Strikingly, changing the rate of exit from the state AD2 (d2-) caused a uniform shift in the recovery rate (E) Summary plot shows glutamate potency (EC 50 , filled circles) and recovery rate (k rec ) against the value of d2-in each simulation. (F) Varying the unbinding rates from the desensitized state (kd-, red) and the resting state (k-, green, to enforce microscopic reversibility) gave rise to at most a 10-fold shift in recovery rate, but shifted glutamate potency by more than 2 orders of magnitude (blue circles). Simulations were done on two backgrounds: either low (0.5 s À1 , open circles) or high values of d2-(100 s À1 , filled circles).
(G) Varying the exit rate from the first desensitized state (red) could not reproduce fast recovery on a background of slow value of d2-(open circles) or slow recovery on a fast value of d2-(filled circles). The unbinding rate from the desensitized state (kd-, green) was altered to impose microscopic reversibility.
(k rec ) over 3 orders of magnitude, comfortably covering the range between GluA2 and GluK2, and our chimeric receptors (Figure 2B) . The variation in d2-was the only modification that accounted well for all our observations, including the development of a large steady state current in the presence of 10 mM glutamate for fast recovering channels (B2P6; compare Figure 2C and Figure 1C ). Similarly to our observations for chimeric receptors, the peak current-concentration relation was not changed by variation in the exit rate from AD2 ( Figure 2D ). In contrast, reducing bound lifetime on the background of slow recovery (by changing the rates k-and kd-) could not produce the fast recovery of wild-type GluA2 and B2P6. Although slower recovery is possible by slowing dissociation on a fast recovering background, this is accompanied by major shifts and distortions of the concentration response relation ( Figure 2F ). This scenario reproduced well the findings of previous reports where mutations at the jaws of the LBDs alter the stability or lifetime of all glutamate bound states (Robert et al., 2005; Weston et al., 2006b ). However, apparent affinity was altered little in our chimeras, ruling out changes in resting state affinity as the sole explanation for the physiological difference between AMPA and kainate receptors, and between our chimeras. The similar rate of entry to desensitization for AMPA and kainate receptors, and similar peak open probability, rules out significant changes in the transition AR -AD, but variation in the reverse transition (d1-) could conceivably produce different recovery ratesperhaps corresponding to different re-association kinetics of the active LBD dimers. We repeated the simulations, varying the rate of exit from the AD state, again on two backgrounds, slow and fast exit from the AD2 state ( Figure 2G ). These simulations failed to give a wide range of recovery rates. Rather, the simulated currents strongly resembled the results of manipulations that stabilize the D1 dimer interface (data not shown). The variation in exit from AD on a background of fast recovery resembled the effect of the L483Y mutant or allosteric modulators such as cyclothiazide (Sun et al., 2002) . The same manipulation on a slow background reproduced the effects of stabilizing the GluK2 D1 dimer interface with mutations (Chaudhry et al., 2009b) . More complex covariations of multiple rate constants (or more realistic activation mechanisms) could potentially also recreate our observations. However, the kinetic behavior caused by variation in the lifetime of a deep desensitized state is quite distinct from the effects reported in previously published studies (see above). This distinction drew us to investigate differences between GluA2 and GluK2, located away from previously described sites that could differentially stabilize a glutamate-bound, deep desensitized state.
Residues that Control the Lifetime of the Desensitized State in AMPA Receptors
The ligand binding domains of AMPA and kainate receptors are bilobed clamshell structures, comprising $250 amino acids of highly conserved sequence (65% identity between GluA2 and GluK2). Mutations in the upper lobe (D1) that do not involve ligand contacts can alter desensitization entry rates, but have minimal effects on recovery from desensitization (Horning and Mayer, 2004 ; Stern-Bach et al., 1998). Likewise, intrasubunit interactions at the clamshell jaws of the LBDs alter both recovery and potency (Weston et al., 2006b; Robert et al., 2005) . Because rates of entry to desensitization and the potency of glutamate to activate the receptor are similar in our chimeric receptors, these regions do not determine the large difference in desensitized lifetime between GluA2 and GluK2. We therefore turned our attention to residues within the lower lobe (D2) that do not make contacts with D1. We formed a panel of 16 mutants in GluA2 ( Figure S3 ), substituting the corresponding residue or sequence from GluK2, and screened these for slowed recovery from desensitization.
Fast desensitizing glutamate-activated currents were obtained from 15 of the 16 mutants (Table 1 and Table S1 ), but most (11) failed to slow the rate of recovery from desensitization more than 2-fold, relative to wild-type GluA2. Some mutations accelerated recovery. Two exchanges near to the base of the LBD provoked recovery kinetics distinct from wild-type (Figures 3A and 3B) . A mutation at the base of helix I, E713T, slowed recovery about 3-fold compared to wild-type GluA2 (k rec = 16 ± 3 s À1 ; n = 6, Hodgkin-Huxley fit with slope 2). The Y768R mutation, in helix K, made recovery monoexponential (as in GluK2), with k rec = 15 ± 1 s À1 (n = 10 patches). When these two mutations were combined (GluA2 E713T Y768R; hereafter TR) the slowing of recovery was supra-additive, with k rec = 1.1 ± 0.2 s À1 (n = 10 patches, Figures 3C and 3D ). This rate is more than 40-fold slower than wild-type GluA2. Including the mutation S652D in the jaws of the LBD, to increase glutamate affinity (Weston et al., 2006b) , produced a poorly expressed receptor (GluA2 DTR) that had even slower recovery from desensitization than GluK2 wild-type (GluA2 DTR k rec = 0.4 ± 0.1 s À1 , n = 6 patches) ( Figure 3E ). Consistent with the close physical apposition of E713 and Y768 (see Figure 3F and Discussion), mutant cycle analysis suggested a degree of energetic coupling between these two residues for recovery from desensitization (DDG = 1.6 ± 0.4 kT; Figure S4 ). In wild-type receptors and our chimeras, despite large shifts in recovery rate, EC 50 values are similar ( Figure S1B ). We measured peak currents for the GluA2 TR double mutant activated by concentration jumps of glutamate, largely avoiding desensitization ( Figure 4A ). The glutamate EC 50 was 230 ± 20 mM (n = 5 patches), similar to wild-type GluK2 channels, confirming that slowing of recovery is not due to an inordinate increase in glutamate potency. Glutamate activated the GluA2 Y768R single mutant with EC 50 = 640 ± 90 mM (n = 5, data not shown), so it is plausible that the other mutants in our panel are activated by glutamate with a potency similar to wild-type GluA2.
If glutamate binds more tightly to the desensitized state, steady-state desensitization should occur at lower glutamate concentrations. We measured the IC 50 for desensitization by glutamate using concentration jumps, with pre-exposure to a range of glutamate concentrations (see Experimental Procedures). For GluA2, as previously reported (Plested and Mayer, 2009) , the half-inhibitory concentration (IC 50 ) was more than 100-fold lower than the EC 50 for activation (9 ± 1 mM; n = 3-11 patches per point; Figure 4B ). Glutamate is even more potent at inhibiting the slow recovering GluK2 receptor (IC 50 = 700 ± 80 nM, n = 3-8 patches). Consistent with the much slower recovery of the TR mutant, glutamate also blocked activation potently, at about 1,000-fold lower concentration than the EC 50 for activation (IC 50 = 240 ± 30 nM; n = 5-7 patches). The GluA2 Y768R single mutant was also more potently inhibited by glutamate than wild-type GluA2 (IC 50 = 3 ± 0.3 mM, data not shown). These data demonstrate that the GluA2 TR mutant and GluK2 bind glutamate much more tightly in the desensitized state than wild-type GluA2 does.
Fast Recovery Is Correlated with Fast Deactivation
For our panel of GluA2 mutants, we also measured the rate of deactivation following a 1 ms pulse of saturating glutamate. This experiment approximates synaptic transmission, where Figure S3 for an sequence alignment of D2 residues and Figure S4 for evidence of thermodynamic coupling between E713 and Y768. (D) A strong correlation (Pearson r = 0.82, 95% confidence interval 0.56 to 0.94) between deactivation and recovery rates for the panel of GluA2 mutants (circles) holds over more than 2 orders of magnitude of recovery rate. Orthogonal distance regression fitted a line with slope 26 ± 3. There was no correlation between the entry and exit rates for desensitization (diamonds, slope 0.01 ± 0.1, r = 0.01, 95% confidence interval À0.5 to À0.5). Wild-type values are indicated with filled symbols.
the glutamate transient decays in about 1 ms (Clements et al., 1992) . Slow-recovering receptors (for example, the GluA2 TR double mutant) had slower deactivation decays than wild-type GluA2 ( Figure 4C and Table 1 ). We plotted the deactivation rate and the desensitization rate of each mutant against the recovery rate ( Figure 4D) . Strikingly, the deactivation rate and the recovery rate were strongly correlated (Pearson r = 0.82). The correlation also held for mutants where recovery was faster than wild-type channels, which tended to have faster deactivation. There was little correlation between the rate of recovery and rate of entry to desensitization (Pearson r = 0.01), which varied less than 2-fold across the entire panel (range 89-159 s À1 , Table 1 and Table S1 ).
Open Periods Are Extended in the TR Mutant
The correlation between deactivation and recovery rates, accompanied by modest changes in glutamate apparent affinity, suggests that mutations in D2 might alter activation gating, in particular by lengthening apparent openings. We investigated this hypothesis by recording the activations of individual wildtype and A2 TR channels in 10 mM glutamate ( Figure 5A ). Long (8 s) applications of 10 mM glutamate to patches containing 5-100 channels produced an initial peak response, followed by well-spaced activations with two or three subconductance levels ( Figure 5B ), and a rare full conductance level, as previously reported (Zhang et al., 2008) . The mean gap between activations of a single channel (corrected for the number of channels, as estimated from the peak response) was about 500 ms for WT (n = 4 patches) and about 2,500 ms for TR (n = 4). Channels were saturated with glutamate during these intervals, and so these gaps cannot be compared to the rate of recovery from desensitization, which occurs in the absence of glutamate. Nonetheless, the longer gaps exhibited by the TR mutant are consistent with a more stable desensitized state.
The distributions of open periods, which were well fitted with double exponential densities ( Figure 5C ), suggested that many openings were too brief to be detected. Apparent openings are extended by missed shuttings, but this effect should be similar for both A2 wild-type and the TR mutant because of the similarity in their shut time distributions ( Figure 5C ). With this caveat in mind, we detected a highly significant 2-fold increase in the mean open period in the A2 TR mutant (from 900 ± 100 ms to 1,900 ± 200 ms; p = 0.0028, n = 4 patches for each mutant, Figure 5D ). The time constant of the slower component of the distribution increased from 1.8 ms (55% of open periods on average, n = 4 patches) to 4.3 ms (41% of open periods). No exact missed event correction is available for data containing sublevels, so we cannot perform maximum likelihood fitting (Colquhoun et al., 2003) to interpret the prolonged openings in terms of mechanisms. 2-D plots of amplitude against open period revealed no correlation between these two properties for wild-type or mutant receptors (Figure S5) , suggesting that no specific sublevel is associated with altered gating. Consistent with this idea, the mean conductance, weighted by occupancy, for the A2 TR mutant ( Figure 5E ; 19 ± 1 pS; n = 4 patches) was indistinguishable from wild-type GluA2 (18 ± 1 pS; n = 4). The mean burst length during applications of 10 mM glutamate was 8 ± 2 ms (that is, the rate of bursts ending was 130 ± 30 s À1 ) for WT and 7 ± 1 ms (110 ± 20 s À1 ) for TR. If we assume that almost all bursts were terminated by desensitization, the inverses of these burst lengths correspond well to the desensitization time constants (see Table 1 ).
Domain 2 Also Controls Recovery and Decay Times in Kainate Receptors
Previously published work established that individual substitutions in the D2 domain of GluK2 fail to alter the entry rate for desensitization, and at most provide 5-fold speeding of recovery (Fleck et al., 2003) . The strong effect of the TR mutant on AMPA receptor recovery guided us to examine the substitutions T715E and R769Y in GluK2 (equivalent to E713T and Y768R in GluA2). However, individual mutations at this site alone gave at best minor speeding of recovery (Table 1) , and the tandem exchange slowed recovery. In GluK2 (PDB: 3G3F (Chaudhry et al., 2009a) ), helix I and helix K approach closer than in GluA2, with T715 and R769 pointing in opposite directions, possibly explaining the limited effect. Instead, combining mutants distributed across the lower lobe of the GluK2 LBD (see Figures 6A and 6B ) was much more efficacious. As in the case of the triple DTR mutant in GluA2, the cumulative effect of combining mutations was to reduce the amplitude of membrane currents and we obtained numerous ''blank'' patches for triple mutants. Of the two quadruple mutant combinations we made, one was nonfunctional (GluK2 D656A S675R M706L T715E) and the other typically gave patch currents in the 10 pA range. This quadruple mutant (GluK2 E650A S675R M706L T715E; ARLE) recovered about 20-fold faster than wildtype GluK2 (Figures 6C and 6D ; 8.6 ± 0.7 s À1 , n = 6 patches), with a halftime of recovery (t 50 ) of 80 ms, only about 3-fold longer than wild-type GluA2 (26 ms). Quintuple and sextuple combinations (e.g., GluK2 L511M Y512I E650A S675R M706L T715E) also failed to give expression of membrane currents. We were not able to measure glutamate apparent affinity for the quadruple ARLE mutant because currents were small and exhibited strong rundown. The triple S675R M706L T715E mutant (GluK2 RLE) had glutamate potency slightly lower than that at wild-type GluA2 (EC 50 = 2.8 ± 0.1 mM, n = 5 patches). The potency of glutamate at the M706L single mutant was indistinguishable (EC 50 = 3.1 ± 0.3 mM, n = 10 patches), even though the RLE mutant recovers about twice as fast as M706L alone (Table 1) . Notably, a similar 20-fold shift in potency due to point mutations in the jaws of GluK2 (Weston et al., 2006b ) such as K456A, only speeds recovery 4-fold (compared to the more than 10-fold speeding for GluK2 RLE).
Mutations that sped K2 recovery also sped up the deactivation decay ( Figure 6E ), mirroring the situation in AMPA receptors, and we obtained a similar correlation across the mutant series ( Figure 6F , Pearson r = 0.64 for the correlation between k rec and k deact ). Only one mutation (GluK2 L511M Y512I) altered the desensitization rate outside a 2-fold range across the entire series, closely matching the situation in AMPA receptors (Table S1 ; Pearson r = -0.01 for the correlation between k rec and k des ).
A Simple Activation Mechanism that Accounts for the Observed Correlations
A positive correlation between recovery and deactivation rates is expected if glutamate affinity changes for all states. Such a change should also strongly alter glutamate potency for channel activation, a phenomenon that we detected only in GluK2 constructs harboring the M706L mutation. The behavior of other mutants, such as A2 TR, for which deactivation decays and recovery both changed with only limited shifts in EC 50 , are not predicted by the mechanism in Figure 2A (data not shown). We reasoned that the correlation could be recapitulated by linking the open state to the deep desensitized state. Schemes with long lived desensitized states connected to open states were previously proposed to describe the activation of native glutamate receptors (Hä usser and Roth, 1997; Jonas et al., 1993) . However, in other studies, desensitization was taken to proceed only from shut states (Vyklicky et al., 1991; Robert and Howe, 2003) or from either shut or open states (Lin and Stevens, 1994; Raman and Trussell, 1995) , and the concept of desensitization from open states has remained controversial (Colquhoun and Hawkes, 1995a) . Because connecting these two states forms a reversible loop, changes in the rate d2-must be compensated by changes in another rate constant to ensure microscopic reversibility is obeyed (Colquhoun et al., 2004) . We performed extensive trial simulations (data not shown) allowing various rate constants on the loop to covary with d2-(see Figure 7A) . A tolerable representation of the observed kinetic behavior of our mutant panel was only obtained if the rate of channel closure (a) was varied with d2-. This regime allowed shifts in the recovery rate of more than 2 orders of magnitude ( Figure 7B ). The deactivation rate was altered in the same range as our mutant series ( Figure 7C ). Slower rates of channel closure for slower recovering channels also predict longer individual channel openings, as we observed for the A2 TR mutant. Despite the range of efficacies (b/a) being greater than 1,000-fold, the model predicted only limited effects on the peak open probability and extent of steady-state desensitization (because these properties are principally determined by the ratios b / d1+ and d2*+ / d2*À, respectively). At slow recovery rates, the foot of the concentration response relation was distorted ( Figure 7E ), but the shifts in glutamate potency were modest, as for the A2 TR mutant ( Figure 4A ). Predicted recovery and deactivation rates were positively correlated, and approximately fit by a power law relation, with exponent about 1.5 ( Figure 7G ). As in our mutant series, the predicted desensitization rate was barely altered across the entire range of recovery rates. We investigated if our original model (Figure 2A ) could describe the observed data, if both a and d2-were varied without a connection between the desensitized and open states, but rate of entry to desensitization varied strongly with recovery rate in this case (data not shown), in direct opposition to our observations ( Figures 4D and 6F ). The deviation from the linear correlation observed in the mutant panel may be due to the oversimplification of our model, relative to the true activation mechanism, and is one indication that further work to refine these activation mechanisms is necessary. Nonetheless, this simple reaction scheme shows that covariation of open and desensitized state lifetimes, due to reversibility constraints or other mechanisms, can lead to the correlations that we observed for our mutant series.
DISCUSSION
Our chimeras and mutant screens demonstrate that domain 2 of the AMPA and kainate receptor ligand binding domains determine both the lifetime of the desensitized state and the deactivation decay. These surprising results augment the established idea that the chemistry and dynamics of the ligand binding domains are central in determining glutamate receptor kinetic behavior. Our results exclude agonist potency as the basis of the difference in recovery rate between wild-type receptors. Consistent with this observation, none of the mutations that shift recovery contribute directly to the glutamate-binding pocket. Instead, our kinetic simulations predict that the most plausible explanation for our observations is the existence of a deep desensitized state in kainate receptors that is much less stable in AMPA receptors. Similar desensitized states, from which unbinding of glutamate should be slow, have been proposed before for AMPA receptors (Robert and Howe, 2003) . This suggests a state where the closure of the ligand binding clamshells is stabilized by interactions that allow glutamate to stay trapped when the channel is closed.
Entry to desensitization occurs by the common mechanism of D1 dissociation in AMPA and kainate receptors (Chaudhry et al., 2009a; Sun et al., 2002) , and is controlled by subunit interfaces between domains 1. In contrast, we show that sites in D2 alter recovery profoundly, but are unlikely to mediate direct interactions between subunits. For example, destabilization of desensitized dimers in GluA2 by E713, through electrostatic repulsion or steric hindrance, which could be relieved by the E713T mutation, is implausible, because the C-alphas of E713 are separated by 29 Å in the candidate GluA2 LBD desensitized dimer (Armstrong et al., 2006) . The chimeras we used in this study include part of the pre-M4 linker, but it is unlikely that this segment has an influence on recovery. Chimeras with a boundary N-terminal to this linker, at a conserved double tryptophan motif (WW; Figure S6 ), although largely retained in the endoplasmic reticulum, had indistinguishable recovery characteristics to the chimeras we used.
Although the active dimers of LBDs are likely to be the same in AMPA and kainate receptors (Weston et al., 2006a) , a full-length structure placing these dimers in context is available only for GluA2 bound with antagonist (Sobolevsky et al., 2009) . The organization of the four LBDs in the desensitized state might differ between receptor classes, allowing for differences in stability, but several of our observations suggest that any interdimer interactions are limited. Although engineered interdimer disulfide bonds crosslink sites in helices G and K in GluK2 (Das et al., 2010) , the adjacent S679R mutation in helix G of GluK2 was only effective in speeding recovery as a member of a set of exchanges. Further, the recovery of the GluK2 N771K mutant, the equivalent crosslinking site in helix K, and of GluA2 mutants harboring the reverse exchanges, were indistinguishable from those of the respective wild-type receptors (Table 1 and Table S1 ).
If direct intersubunit interactions are not responsible for the shift in desensitization state lifetime, two other major possibilities remain. First, domain 2 could adopt multiple orientations relative to domain 1 during desensitization, perhaps corresponding to the different distances discerned in single molecule FRET studies, which are otherwise too slow to be involved in gating (Landes et al., 2011) . These orientations could differ between AMPA and kainate receptors. Second, domain 2 might deform between different functional states rather than translating purely as a rigid body during gating motions. Distributed mutations could alter the balance between different conformations to alter recovery. In NMDA receptors, the redox state of the disulfide bond at the base of domain 2 might alter receptor activity by allowing deformation of D2 (Choi et al., 2001) . NMR studies revealed that the beta core of domain 2 in GluA2 is the most mobile part of the LBD (McFeeters and Oswald, 2002) . Ligand selective chemical shifts are also detected for the region around the conserved disulfide bond (abutted by Glu 713 in GluA2) and helix I (Valentine and Palmer, 2005) . Domain 2 exhibits ligand-specific conformations in GluN2D subunits (Vance et al., 2011) , and domain 2 generally has higher crystallographic temperature factors than domain 1, but detecting conformational plasticity through crystallographic studies at the relevant sites might be challenging. In GluA2, Tyr 768 lies at the C terminus of the soluble LBD, which is often engineered to permit crystallization (Mayer et al., 2006) , and is also often disordered. Molecular dynamics simulations and NMR studies may provide insights into how D2 dynamics control glutamate receptor gating.
We have obtained a double-mutant AMPA receptor with very slow recovery, which may find application as a tool to study desensitization in native cells. In contrast, serial exchanges were necessary to obtain fast recovering kainate receptors. Could fast recovery be an essential adaptation in AMPA receptors that required extensive tuning, and which can be ''broken'' comparatively easily? Collecting sufficient data to examine this idea properly seems impractical, because quaternary (and higher order) combinations of mutations in GluK2 express so poorly. We know that complete exchange of the intact ligand binding domains swaps both recovery and deactivation kinetics between AMPA and kainate receptors. In this case, the swapped LBDs contain all necessary nonconserved variations to confer functional differences, but presumably also harbor coevolved second-site suppressors to maintain efficient folding, stability, and maturation, which perhaps our point mutants lack.
The observed correlation between deactivation rate (k deact ) and recovery from desensitization (k rec ) has implications for the activation mechanisms of AMPA and kainate receptors. These coupled kinetic properties are tuned during brain development through changes in subunit composition at synapses. One example is in neurons of the auditory pathway, where AMPA receptor EPSCs are accelerated at hearing onset, as GluA1-containing receptors are replaced by those incorporating the faster recovering GluA4 subunit (Joshi et al., 2004; Taschenberger and von Gersdorff, 2000) . Recapitulation of the correlation by a simple mechanism in which the open state and the desensitized state are connected suggests the possibility that the same molecular interactions that slow recovery also slow channel closure. Because the structures of the open and deep desensitized states are likely to differ appreciably, the connection between open and desensitized states may consist of multiple transitions. Such a correlation could also result without desensitization from the open state, but other features of our data are not described in this case. Simple changes in affinity do not predict the existence of mutants (or wild-type receptors) where apparent affinities do not differ much but which have dramatically different recovery. In NMDA and GABA receptors, agonist unbinding is slow. Thus long shut sojourns (which may involve desensitized states) contribute considerably to the synaptic decay for both receptor classes. Reopening of NMDA and GABA receptors following a long shut state occurs because the channel opening rate is similar to the unbinding rate (Jones and Westbrook, 1995; Popescu et al., 2004) . If AMPA channels are functioning in a similar way, only accelerated about 100-fold, faster recovery of receptors from the desensitized state and speeding of channel closure might be a way of sharpening the synaptic current and limiting noise by minimizing reopening, as well as ensuring maximum availability of receptors over a wide input bandwidth.
EXPERIMENTAL PROCEDURES Molecular Biology
To construct S1S2 chimeras, we amplified inserts containing the GluA2 or GluK2 ligand binding domains with splice sites to the parent backbone via overlap PCR. Domain boundaries, which were sequence neutral, were as follows: B2P6 -K2 (T1-N399) A2 (N382-P507) K2 (P513-S635) A2 (S631-K781) K2 (K779-A877); B6P2: A2 (V1-N382) K2 (N399-P513) A2 (P507-S631) K2 (S635-K779) A2 (K781-I862). Point mutations were introduced by overlap PCR and confirmed by double-stranded sequencing. Numbering refers to the mature polypeptide chain.
Cell Culture and Electrophysiology
Wild-type and mutant glutamate receptors were overexpressed in HEK293 cells as described (Chen et al., 1999) . For most experiments, the external solution contained (in mM): 150 NaCl, 0.1 MgCl 2 , 0.1 CaCl 2 , and 5 HEPES, titrated to pH 7.3 with NaOH, to which we added drugs as required. In experiments to assess the ion sensitivity of chimeras, we replaced NaCl with NaNO 3 or CsCl. Drugs were obtained from Ascent Scientific (Weston-Super-Mare, UK). The pipette solution contained (in mM): 115 NaCl, 10 NaF, 0.5 CaCl 2 , 1 MgCl 2 , 5 Na 4 BAPTA, 5 HEPES and 10 Na 2 ATP (pH 7.3). We applied ligands to outside out patches via a piezo driven fast perfusion system. Typical 10%-90% solution exchange times were faster than 300 ms, as measured from junction potentials at the open tip of the patch pipette. For single-channel recording, outside-out patches were clamped at -80mV during long applications (8 s) of 10 mM glutamate. Records were filtered at 1-2 kHz and idealized using time course fitting (SCAN, available from onemol.org.uk).
Data Analysis
To measure recovery from desensitization, we used a two-pulse protocol with a variable interpulse interval. Recovery data were fitted by a HodgkinHuxley-type function:
where N is the active fraction of receptors at time t following the first pulse, N 0 was the active fraction at the end of the conditioning pulse, and k rec was the rate of recovery. Concentration-peak current data were fitted with Langmuir single binding isotherms:
where I(x) was the response at glutamate concentration, x; I max the maximum response; and EC 50 the concentration of half-maximal activation. For measurements of equilibrium desensitization, we bathed the patch in low concentrations of glutamate via the control barrel. Residual responses to 10 mM glutamate were fitted with the following equation:
where I(x) was the response following preincubation at a given concentration of glutamate, x; I max was the maximum response; and IC 50 was the concentration of half-maximal inhibition.
Kinetic Modeling
We calculated the relaxations for simplified activation mechanisms, in line with previously published work (Robert et al., 2005) . For each simulation, the mechanism was encoded by a Q-matrix, microscopic reversibility was imposed on any cycles (Colquhoun et al., 2004) and relaxations were calculated using standard methods (Colquhoun and Hawkes, 1995b) . We then calculated the occupancy of the various states in the model during relaxations (P(t)) according to the following equation (Colquhoun and Hawkes, 1977) : PðtÞ = P0$exp½ÀQt P 0 is the initial occupancy of the states in the mechanism. Further information is found in the Supplemental Experimental Procedures.
Figures were prepared with Kaleidagraph (Synergy Software), Igor Pro (Wavemetrics), and Pymol. Results are reported as the mean ± SD of the mean, and significance was assessed with Student's t test (two-tailed distribution).
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental Experimental Procedures and can be found with this article online at doi:10. 1016/j.neuron.2012.04.020.
